Trial intelligence / Profile preview

ALPACA trial of antibiotic peritoneal lavage after laparoscopic appendectomy for complicated appendicitis

NL-OMON60311Phase 3Recruiting

Sponsor
Amsterdam University Medical Center
Start
Feb 2025
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 3, randomised, open-label trial of clindamycin and gentamicin in appendicitis (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Incidence of postoperative intra-abdominal abscess. Started Feb 2025; status: recruiting.

02

Drugs

clindamycingentamicin
03

Conditions

appendicitis

Beyond the preview

Go deeper on NL-OMON60311.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON60311.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call